Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: TRAIL promotes hepatocellular carcinoma apoptosis and inhibits proliferation and migration via interacting with IER3

Fig. 1

TRAIL inhibited cell growth in HCC cells. a BEL7402, HepG2, Huh7, Hep3B, and SMMC7721 cells were treated for 96 h using the indicated doses of recombinant human TRAIL, after which growth was assessed via MTT assay. Data are means ± SD of triplicate samples. Results are the average of three experiments. **P < 0.01, Dunnet’s post-hoc test. b, c BEL7402 and Huh7 cells were administered the indicated Ad5-TRAIL doses for the indicated time periods. **P < 0.01

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us